Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sosthène Essono"'
Autor:
Yves Bourne, Ludovic Renault, Sosthène Essono, Grégoire Mondielli, Patricia Lamourette, Didier Boquet, Jacques Grassi, Pascale Marchot
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77226 (2013)
The inhibition properties and target sites of monoclonal antibodies (mAbs) Elec403, Elec408 and Elec410, generated against Electrophorus electricus acetylcholinesterase (AChE), have been defined previously using biochemical and mutagenesis approaches
Externí odkaz:
https://doaj.org/article/1b430b6ac41040e18c89120f4c425741
Autor:
Marie Hautiere, Irene Maffucci, Narciso Costa, Amaury Herbet, Sosthene Essono, Séverine Padiolleau-Lefevre, Didier Boquet
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 3 (2023)
ABSTRACTmAbs play an essential role in the therapeutic arsenal. Our laboratory has patented the Rendomab-B49 mAb targeting the endothelin B receptor (ETB). This G protein-coupled receptor plays a driving role in the progression of numerous cancers. W
Externí odkaz:
https://doaj.org/article/5457d5c48a09474cae6ab11171ce34f8
Autor:
Ruijiang Song, Saied Mirshahidi, Sosthène Essono, Xiao-Wei Wang, Sergei Popov, Ruth M. Ruprecht
Publikováno v:
DNA and Cell Biology. 28:103-108
We developed a rapid method to generate recombinant vaccinia viruses (rVVs) based upon a bicistronic cassette encoding the gene for green fluorescent protein (GFP) and a foreign gene of interest separated by an internal ribosome entry site (IRES). As
Autor:
James B. Whitney, Sandra J. Lee, Sosthène Essono, Victor G. Kramer, Karen S. Anderson, Saied Mirshahidi, Glenn Dranoff, Ruth M. Ruprecht
Publikováno v:
Vaccine. 27:1825-1833
Peptide-based vaccines, one of several anti-tumor immunization strategies currently under investigation, can elicit both MHC Class I-restricted (CD8(+)) and Class II-restricted (CD4(+)) responses. However, the need to identify specific T-cell epitope
Autor:
Pascale Marchot, Didier Boquet, Jacques Grassi, Yves Bourne, Marianick Juin, Sosthène Essono, Ludovic Renault
Publikováno v:
Chemico-Biological Interactions. :397-400
The target sites of three inhibitory monoclonal antibodies, Elec403, 408 and 410, on eel AChE have been defined previously. Elec403 and 410 are directed toward distinct but overlapping epitopes at the enzyme peripheral site, while Elec408 binds to a
Publikováno v:
Journal of Immunological Methods. 279:251-266
The amplification of variable regions of immunoglobulins by reverse transcription polymerase chain reaction (RT-PCR) has become an invaluable technique either for the cloning of monoclonal antibodies (mAbs), or for the building of single-chain fragme
Autor:
Vivekanandan Shanmuganathan, Anton M Sholukh, Shiu Lok Hu, Peter H. Schur, Maria Kahn, Ruth M. Ruprecht, Hemant K. Vyas, Jennifer D. Watkins, Girish Hemashettar, Michael Humbert, David C. Montefiori, Victoria R. Polonis, Sosthène Essono, Muhammad Mukhtar
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 6, p e38943 (2012)
PLoS ONE, Vol 7, Iss 6, p e38943 (2012)
Existing technologies allow isolating antigen-specific monoclonal antibodies (mAbs) from B cells. We devised a direct approach to isolate mAbs with predetermined conformational epitope specificity, using epitope mimetics (mimotopes) that reflect the
Autor:
Gilles Clément, Sosthène Essono, Jacques Grassi, Christophe Créminon, Séverine Padiolleau-Lefèvre, Didier Boquet
Publikováno v:
Protein Engineering, Design and Selection
Protein Engineering, Design and Selection, Oxford University Press (OUP), 2010, 23, pp.203-210. ⟨10.1093/protein/gzp071⟩
Protein Engineering, Design and Selection, 2010, 23, pp.203-210. ⟨10.1093/protein/gzp071⟩
Protein Engineering, Design and Selection, Oxford University Press (OUP), 2010, 23, pp.203-210
Protein Engineering, Design and Selection, Oxford University Press (OUP), 2010, 23, pp.203-210. ⟨10.1093/protein/gzp071⟩
Protein Engineering, Design and Selection, 2010, 23, pp.203-210. ⟨10.1093/protein/gzp071⟩
Protein Engineering, Design and Selection, Oxford University Press (OUP), 2010, 23, pp.203-210
International audience; The development of therapeutic recombinant antibodies involves accurate characterization of immunoglobulin variable light (VL) and heavy (VH) chains. However, it has been reported that the use of subgroup or isotype-specific p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5a98c7026c5b1d006dc7a66cb420814
https://hal.archives-ouvertes.fr/hal-00468465
https://hal.archives-ouvertes.fr/hal-00468465
Autor:
Sosthène Essono, Fatima Dkhissi, Séverine Padiolleau-Lefevre, Jean-Yves Couraud, Coralie Alexandrenne, Anne Wijkhuisen, Didier Boquet, Gilles Clément, Celine A. Blache
Publikováno v:
Molecular Immunology
Molecular Immunology, Elsevier, 2007, 44 (8), pp.1888-1896. ⟨10.1016/j.molimm.2006.09.035⟩
Molecular Immunology, 2007, 44 (8), pp.1888-1896. ⟨10.1016/j.molimm.2006.09.035⟩
Molecular Immunology, Elsevier, 2007, 44 (8), pp.1888-1896. ⟨10.1016/j.molimm.2006.09.035⟩
Molecular Immunology, 2007, 44 (8), pp.1888-1896. ⟨10.1016/j.molimm.2006.09.035⟩
Since antibodies currently constitute the most rapidly growing class of human therapeutics, the high-yield production of recombinant antibodies and antibody fragments is a real challenge. Using as model a monoclonal antibody directed against the huma
Autor:
Ludovic, Renault, Sosthène, Essono, Marianick, Juin, Didier, Boquet, Jacques, Grassi, Yves, Bourne, Pascale, Marchot
Publikováno v:
Chemico-biological interactions.
The target sites of three inhibitory monoclonal antibodies, Elec403, 408 and 410, on eel AChE have been defined previously. Elec403 and 410 are directed toward distinct but overlapping epitopes at the enzyme peripheral site, while Elec408 binds to a